Remove 2022 Remove Competition Remove Pharma Remove Specialization
article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 108
article thumbnail

The Value of Precision Livestock Farming (PLF) in 2022

Celeritas

Monitoring and analysis of special and temporal data on cattle location, movement, and interaction can provide benefits such as. The provision of a competitive advantage over other dairy suppliers also plays a major role in the considerations. Checking their current physical condition. Determining which animals are high-performing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biopharma struggling to find talent with adequate digital skills

European Pharmaceutical Review

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

article thumbnail

The Top 10 Clinical Research Companies in the USA

Medico Reach

To bring effective medicines and Innovations in healthcare industry , a Clinical Research Organization or Contract Research Organization (CRO) are a must for the Biotech, Medtech, and pharma industries. In 2022, the global clinical research market stands at $63.6 from 2022 to 2027. from 2022 to 2027.

article thumbnail

Employer Branding: The Secret Sauce to Accelerate Recruitment and Address Skills Gaps for Life Sciences Companies

Pharma Marketing Network

Randstad Sourceright’s 2022 Talent Trends report found that a third of C-suite and human capital leaders in the life sciences and pharmaceuticals companies say talent scarcity is a major pain point for the sector. But in the last few years, the industry has started facing a new challenge—talent shortages. Look to experts for guidance.

article thumbnail

Nine for 2023, part one: a reflection on inflection

pharmaphorum

Regulatory divergence became apparent in 2022 and could increase in 2023. For pharma, the impact in critical areas such as the performance of newly marketed innovation has already been documented. Pharma is on a journey in which the core consideration was once the prescriber, now patient needs are more commonly considered as central.

article thumbnail

How PharmaKinnex Helps You Plan For A Better 2023

PharmaKinnex

How PharmaKinnex Helps You Plan For A Better 2023 September 27, 2022. Everyone knows that over the next few weeks and months, businesses in the pharma marketing industry will meet to discuss next year’s budget. Keep reading to find out more about how our pharma marketing services can help make 2023 your best year yet.

Sales 52